Mirum Pharmaceuticals
MIRM
178 hedge funds and large institutions have $2.08B invested in Mirum Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 77 increasing their positions, 41 reducing their positions, and 18 closing their positions.
94% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 18
88% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 41
16% more call options, than puts
Call options by funds: $7.97M | Put options by funds: $6.87M
11% more funds holding
Funds holding: 161 → 178 (+17)
2% more capital inflows, than outflows
Capital inflows: $215M | Capital outflows: $211M
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
1.44% less ownership
Funds ownership: 113.14% → 111.7% (-1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$29.6M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$19.9M |
| 3 |
State Street
Boston,
Massachusetts
|
+$11.9M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$10.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$9.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BVF Inc
San Francisco,
California
|
-$51.6M |
| 2 |
Cadian Capital Management
New York
|
-$30.3M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$23.2M |
| 4 |
Janus Henderson Group
London,
|
-$20.3M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$13.9M |
MIRM Hedge Fund Activity: Q3 2024 in Review
178 of the 6,987 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q3 2024, worth a combined $2.08B — up 14% from $1.82B a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new MIRM positions and 18 closed out — a net gain of 17 holders — while 77 added to existing stakes and 41 trimmed.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $29.6M. The largest seller was BVF Inc, cutting an estimated $51.6M.
- 178 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q3 2024, up from 161 in Q2 2024.
- Funds reported $2.08B of Mirum Pharmaceuticals stock for Q3 2024, up 14% quarter-over-quarter.
- 35 funds opened new Mirum Pharmaceuticals positions in Q3 2024 and 18 closed out, a net change of +17 holders.
- The largest Mirum Pharmaceuticals buyer in Q3 2024 was Lord, Abbett & Co, an estimated $29.6M added.
- The largest Mirum Pharmaceuticals seller in Q3 2024 was BVF Inc, an estimated $51.6M sold.
Based on aggregated 13F filings for Q3 2024.